Those drugs, called highly-active antiretroviral therapies or HAART for short, have not been shown to be effective with HTLV-1.
Lawo makhambi, abizwa ngemishanguzo esebenza ngamandla kakhulu noma phecelezi HAART, abonakale engasebenzi ngempumelelo ne HTLV-1.